medigraphic.com

2025, Number 1

<< Back Next >>

Rev Hematol Mex 2025; 26 (1)

TLR2 and TLR4 relation with platelet abnormalities in Yucatecan patients with type 2 diabetes

Nakazawa UYE, Villarreal KJD, Quintal OIG, Alonzo SLG, González ELG, López BIA, Chab ESS, Valadez GN, Valencia PG

Language: Spanish
References: 33
Page: 1-14
PDF size: 563.58 Kb.


ABSTRACT

     


REFERENCES

  1. Amaru R, Quispe T, Torres G, Mamani J, et al. Caracterizaciónclínica de la eritrocitosis patológica de altura. RevHematol 2016; 17 (1): 8-20.

  2. Morales OAS, Vela EV, Acosta FG, González PB, et al.Estudio PETRO: evaluación de tromboprofilaxis y riesgoembólico en pacientes hospitalizados en una instituciónde tercer nivel en Bogotá, Colombia. Rev Colomb Neumol2017; 29 (1): 7-18.

  3. Noroña Calvachi CD. Trombofilias hereditarias. Rev CientíficaCiencia Médica 2015; 18 (1): 43-9.

  4. Esmon CT. Molecular circuits in thrombosis and inflammation.Thromb Haemost 2013; 109 (03): 416-20. https://doi.org.10.1160/TH12-08-0634

  5. Stark K, Massberg S. Interplay between inflammation andthrombosis in cardiovascular pathology. Nat Rev Cardiol2021; 18 (9): 666-82. https://doi.org.10.1038/s41569-021-00552-1

  6. Nair V, Singh S, Ashraf MZ, Yanamandra U, et al. Epidemiologyand pathophysiology of vascular thrombosis inacclimatized lowlanders at high altitude: A prospectivelongitudinal study. Lancet Regional Health-Southeast Asia2022; 3. https://doi.org.10.1016/j.lansea.2022.05.005

  7. Gupta N, Zhao Y-Y, Evans CE. The stimulation of thrombosisby hypoxia. Thromb Res 2019; 181: 77-83. https://doi.org.10.1016/j.thromres.2019.07.013

  8. Amaru R, Mamani LF, Mancilla E, Paton D, et al. Transferrinand erythropoietin increased levels correlate with thrombosisat high altitude. Blood 2023; 142: 5548. https://doi.org/10.1182/blood-2023-188302

  9. Olivas-Martinez A, Corona-Rodarte E, Nuñez-Zuno A,Barrales-Benítez O, et al. Causes of erythrocytosis andits impact as a risk factor for thrombosis according toetiology: experience in a referral center in Mexico City.Blood Res 2021; 56 (3): 166-74. https://doi.org.10.5045/br.2021.2021111

  10. Salas Morales GA. Incidencia y caracterización de la TrombosisVenosa Profunda en los pacientes adultos con cáncer,en los hospitales: Honorio Delgado Espinoza, Goyenechee IREN Sur 2017-2018. 2019.

  11. Semenza GL. Regulation of erythropoiesis by the hypoxiainduciblefactor pathway: Effects of genetic and pharmacologicalperturbations. Ann Rev Med 2023; 74: 307-19.https://doi.org.10.1146/annurev-med-042921-102602

  12. Mallet RT, Burtscher J, Richalet J-P, Millet GP, Burtscher M.Impact of high altitude on cardiovascular health: currentperspectives. Vasc Health Risk Manag 2021; 17: 317-35.https://doi.org.10.2147/VHRM.S294121

  13. Jelkmann W. Regulation of erythropoietin production. JPhysiol 2011; 589 (6): 1251-8. https://doi.org.10.1113/jphysiol.2010.195057

  14. Rolfs A, Kvietikova I, Gassmann M, Wenger RH. Oxygenregulatedtransferrin expression is mediated by hypoxiainduciblefactor-1. J Biol Chem 1997; 272 (32): 20055-62.https://doi.org.10.1074/jbc.272.32.20055

  15. Smith KJ, Bleyer AJ, Little WC, Sane DC. The cardiovasculareffects of erythropoietin. Cardiovasc Res2003; 59 (3): 538-48. https://doi.org.10.1016/s0008-6363(03)00468-1

  16. Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, et al.Effects of erythropoietin on platelet reactivity and thrombopoiesisin humans. Blood 2000; 95 (9): 2983-9. https://doi.org/10.1182/blood.V95.9.2983.009k27_2983_2989

  17. Amaru R, Mancilla E, Patón D, Luna J, et al. Eritrocitosispatológicas con niveles de eritropoyetina baja e incrementada:características clínicas y laboratoriales. RevistaMédica La Paz 2022; 28 (1): 27-32.

  18. Rolfs A, Kvietikova I, Gassmann M, Wenger RH. Oxygenregulatedtransferrin expression is mediated by hypoxiainduciblefactor-1. J Biol Chem 1997; 272 (32): 20055-62.https://doi.org.10.1074/jbc.272.32.20055

  19. Semenza GL. Regulation of oxygen homeostasis by hypoxiainduciblefactor 1. Physiology (Bethesda) 2009; 24 (2): 97-106. https://doi.org.10.1152/physiol.00045.2008

  20. Shah BN, Zhang X, Sergueeva AI, Miasnikova GY, et al.Increased transferrin protects from thrombosis in Chuvasherythrocytosis. Am J Hematol 2023; 98 (10): 1532-9.https://doi.org.10.1002/ajh.27021

  21. Méndez Osorio AP. Factores de riesgo de trombosis: Universidadde Talca (Chile). Escuela de Tecnología Médica; 2022.

  22. Wilkerson WR, Sane DC, editors. Aging and thrombosis.Seminars in thrombosis and hemostasis. Thieme MedicalPublishers, 2002.

  23. Campoverde Vintimilla VA. Tromboembolia pulmonaren pacientes adultos mayores diagnóstico y tratamiento.2021.

  24. Raso AG. Dislipemia y obesidad en la enfermedad tromboembólicavenosa: factores de riesgo y complicacionestrombóticas: Universidad Autónoma de Madrid; 2013.

  25. Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity.Curr Opin Hematol 2013; 20 (5): 437-44. https://doi.org.10.1097/MOH.0b013e3283634443

  26. Bryce-Moncloa A, Alegría-Valdivia E, Martin-San MartinS, Mauricio G, editors. Obesidad y riesgo de enfermedadcardiovascular. Anales de la Facultad de Medicina; 2017:UNMSM. Facultad de Medicina.

  27. Amaru R, Velarde J, Mamani R, Carrasco M, et al. Tratamientode la eritrocitosis secundaria en la altura. RevistaMédica La Paz 2020; 26 (2): 16-23.

  28. Amaru Lucana R, Vera Carrasco O. Guía para el diagnósticoy tratamiento de las eritrocitosis patológicas en la altura.Revista Médica La Paz 2016; 22 (2): 70-7.

  29. Torres DZ, Rodríguez MR, Quismondo NC, Martínez-LópezJ. Tratamiento anticoagulante profiláctico. Medicine-Programa de Formación Médica Continuada Acreditado2020; 13 (22): 1280-3.

  30. Tobu M, Iqbal O, Fareed D, Chatha M, et al. Erythropoietininducedthrombosis as a result of increased inflammationand thrombin activatable fibrinolytic inhibitor. ClinApplied Thromb Hemost 2004; 10 (3): 225-32. https://doi.org.10.1177/107602960401000304

  31. Salvati F, Liani M. Erythropoietin and thrombotic events.Lancet 1998; 352 (9138): 1471.

  32. Esmon CT. Basic mechanisms and pathogenesis of venousthrombosis. Blood Rev 2009; 23 (5): 225-9. https://doi.org.10.1016/j.blre.2009.07.002

  33. McDonald AP, Meier TR, Hawley AE, Thibert JN, et al. Agingis associated with impaired thrombus resolution in a mousemodel of stasis induced thrombosis. Thromb Res 2010; 125(1): 72-8. https://doi.org.10.1016/j.thromres.2009.06.005




2020     |     www.medigraphic.com